The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Kurt Geiger general counsel Suzanne Smith is to leave the company to return to the pharmaceuticals sector, joining global biotechnology corporation Genzyme.
Smith joined Kurt Geiger a year ago from pharma company Phoqus Pharmaceuticals, where she was general counsel. She joined Phoqus in February 2005 and was appointed company secretary in January 2007.
Smith will join US company Genzyme later this year as legal director for the UK and Ireland, a role that has been created for her. The biotechnology company headhunted her for the position.
Genzyme has more than 11,000 employees in locations across the globe, including four offices in the UK and one in Ireland.
It develops products and services that focus on rare inherited disorders, including kidney disease, orthopaedics, cancer, transplant and immune disease, as well as diagnostic testing.
Kurt Geiger is currently looking for a replacement.